Category: TCTMD Articles

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

January 07, 2019

Various imaging technologies are relevant to the diagnosis, treatment, and follow-up of patients with nonvalvular structural heart disease. But until now, clinicians needed to consult separate documents for guidance on which tool to choose. New appropriate use criteria (AUC) released today aim to streamline that decision-making by instead focusing on disease states as a whole, rather than on individual modalities.

Visit Website

E-Cigarettes: Plausible Heart Risks Flagged in New Review

December 10, 2018

DUBAI, United Arab Emirates—E-cigarettes are being marketed as safer alternatives to traditional cigarettes and as aids to help people quit smoking, but there is some evidence that they could be having adverse effects on the cardiovascular system, a new review shows.

Visit Website

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

November 15, 2018

Patients with prior MI and elevated high-sensitivity C-reactive protein (hsCRP) see a dose-dependent reduction in heart-failure hospitalization while taking the anti-inflammatory drug canakinumab (Novartis), researchers reported Sunday at the American Heart Association (AHA) 2018 Scientific Sessions in Chicago, IL. The difference between canakinumab and placebo was only significant, however, among patients who achieved on-treatment hsCRP concentrations < 2 mg/L.

Visit Website
Page 1 of 9112345...10152025303540455055...»